The Deciphering Developmental Disorders (DDD) study
Open accessAbstract
One of the main frustrations facing paediatric neurologists, community paediatricians, and clinical geneticists in everyday practice is the poor success rate in making accurate diagnoses for children with severe or profound neurological disability. Accurate diagnosis is the cornerstone of good medical care. However, the chance of achieving a genetic diagnosis for a child with severe developmental delay is low where no diagnosis is apparent after routine investigation – yet the majority of children with developmental disorders fall into this category. Although individually rare, collectively these conditions represent a significant burden for individuals, families, and health services.1 There has been a growing appreciation in recent years of the importance of genetic disorders in childhood neurodisability, although in many cases the location and nature of the causal mutation is unknown. In clinical practice, a family history of other similarly affected individuals is a strong pointer to a genetic aetiology, but the converse does not necessarily hold and the concept that de novo dominant mutations may cause apparently sporadic disorders is gaining acceptance. If a de novo mutation severely impairs development such that the affected individual does not reproduce, the genetic basis of their condition may remain unrecognized. Speculatively, such events may explain some cases of severe cerebral palsy or severe epileptic encephalopathy as well as severe intellectual disability. In addition, there are many undiagnosed recessively inherited neurodevelopmental disorders collectively responsible for a substantial proportion of the excess morbidity and mortality amongst infants born to consanguineous parents.2 Genomic microarray analysis has proven to be valuable for improving rates of diagnosis amongst children with developmental delay/intellectual disability caused by large structural variants (such as deletions and duplications of >50kb).3 For smaller mutations, the revolution in 'next generation' DNA sequencing technologies is now enabling genomic analysis on an unprecedented scale.4 Massively parallel sequencing enables the rapid, systematic identification of variants on a large scale, either across the whole genome or targeted at functional coding regions (the exome). This has accelerated the pace of gene discovery and disease diagnosis on a molecular level5 and may substantially improve the diagnosis of children with developmental disorders.6 The Deciphering Developmental Disorders (DDD) study is an ambitious project, combining the clinical expertise of all 23 UK NHS Regional Genetics Services with the research and bioinformatics expertise of the Wellcome Trust Sanger Institute, to undertake systematic phenotyping and detailed genomic analysis for 12 000 children with severe undiagnosed developmental disorders (Table I). This National Institute for Health Research Portfolio project is funded by the Health Innovation Challenge Fund and the Wellcome Trust Sanger Institute and began recruiting patients in April 2011 (see http://www.ddduk.org). The study will recruit 'trios', i.e. a child and both parents, and use multiple complementary genome-wide approaches – high resolution array-comparative genomic hybridization (aCGH), common variant (SNP) genotyping, and whole exome sequencing – to facilitate identification of de novo variants in the child and improve the chances of identifying relevant recessive mutations. In order to maximize the investment in detailed genomic analysis, the study uses the recently developed Human Phenotype Ontology (HPO)7 which enables comprehensive phenotypic description. The controlled vocabulary in HPO will facilitate association analysis between phenotypes and genomic variants, as well as links to other genetic studies and work in model organisms. The use of whole genome technologies in research and their translation to clinical practice raises numerous social, legal, and ethical issues, such as how to deal with findings that are incidental to the research question or clinical diagnosis.8 Embedded within the DDD project as a core activity is a programme of empirical ethical and social science research, which aims to develop strategies to gain maximum benefit from these new technologies whilst minimizing potential harm. An accurate genetic diagnosis is important for prognosis and management of affected children, and for counselling parents about the likely risk of recurrence. DDD is a translational project and it is hoped that, through the study, several thousand families will receive a genetic diagnosis for their child's developmental disorder. Furthermore, the study will facilitate better design of diagnostic assays and create an important knowledge-base for improved diagnosis of genomic disorders in the future. Analysis of OMIM statistics in April 2011 shows that entries with a phenotype description for which the molecular basis was known totalled 2993. Of an estimated 21 000 genes in
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877 · see citing works
DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources
Firth, H. V., Richards, S. M., Bevan, A. P., Clayton, S., Corpas, M., Rajan, D., Vooren, S. V., Moreau, Y., Pettett, R. M., & Carter, N. P. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.03.010 · Cited by 1,990 · see citing works
Self-citationA de novo paradigm for mental retardation.
Vissers, L. E. L. M., de Ligt, J., Gilissen, C., Janssen, I., Steehouwer, M., de Vries, P., van Lier, B., Arts, P., Wieskamp, N., del Rosario, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.712 · Cited by 852 · see citing works
Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations
Wolf, S. M., Lawrenz, F. P., Nelson, C. A., Kahn, J. P., Cho, M. K., Clayton, E. W., Fletcher, J. G., Georgieff, M., Hammerschmidt, D. E., Hudson, K., et al. (2008) · The Journal of Law Medicine & Ethics · doi:10.1111/j.1748-720x.2008.00266.x · Cited by 710 · see citing works
Manning, M. A., & Hudgins, L. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181f8baad · Cited by 665 · see citing works
Robinson, P. N., & Mundlos, S. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01436.x · Cited by 357 · see citing works
Massively parallel sequencing and rare disease
Ng, S. B., Nickerson, D. A., Bamshad, M. J., & Shendure, J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq390 · Cited by 177 · see citing works
The impact of consanguinity on neonatal and infant health.
Bittles, A. H., & Black, M. L. (2010) · Early Human Development · doi:10.1016/j.earlhumdev.2010.08.003 · Cited by 132 · see citing works
Improving lives optimising resources: a vision for the UK Rare Disease Strategy
Lucas, J. S. (2011) · ePrints Soton (University of Southampton) · Cited by 13 · see citing works
Flagged first, then by citations
1 of the 10 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data
Köhler, S., Doelken, S., Mungall, C. J., Bauer, S., Firth, H., Bailleul-Forestier, I., Black, G., Brown, D. L., Brudno, M., Campbell, J., et al. (2013) · Nucleic Acids Res. · doi:10.1093/nar/gkt1026 · Cited by 840 · see citing works
Self-citationThe Human Phenotype Ontology in 2017
Köhler, S., Vasilevsky, N., Engelstad, M., Foster, E. D., McMurry, J. A., Aymé, S., Baynam, G. S., Bello, S. M., Boerkoel, C. F., Boycott, K. M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1039 · Cited by 757 · see citing works
Self-citationWright, C., Fitzgerald, T. W., Jones, W., Clayton, S., McRae, J., van Kogelenberg, M., King, D. A., Ambridge, K., Barrett, D. M., Bayzetinova, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61705-0 · Cited by 1,794 · see citing works
Self-citationPaediatric genomics: diagnosing rare disease in children
Wright, C. F., FitzPatrick, D. R., & Firth, H. V. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.116 · Cited by 615 · see citing works
Self-citationThe 100 000 Genomes Project: bringing whole genome sequencing to the NHS
Turnbull, C., Scott, R. H., Thomas, E. R. A., Jones, J. L., Murugaesu, N., Boardman-Pretty, F., Halai, D., Baple, E. L., Craig, C. E. H., Hamblin, A. D., et al. (2018) · BMJ · doi:10.1136/bmj.k1687 · Cited by 446 · see citing works
Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity
Coe, B. P., Stessman, H. A. F., Sulovari, A., Geisheker, M. R., Bakken, T. E., Lake, A. M., Dougherty, J. D., Lein, E. S., Hormozdiari, F., Bernier, R. A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0288-4 · Cited by 330 · see citing works
A guide for the diagnosis of rare and undiagnosed disease: beyond the exome
Marwaha, S., Knowles, J. W., & Ashley, E. A. (2022) · Genome Medicine · doi:10.1186/s13073-022-01026-w · Cited by 365 · see citing works
The European Genome-phenome Archive of human data consented for biomedical research
Lappalainen, I., Almeida, J. P., Kumanduri, V., Senf, A., Spalding, D., Ur-Rehman, S., Saunders, G. I., Kandasamy, J., Cáccamo, M., Leinonen, R., et al. (2015) · Nature Genetics · doi:10.1038/ng.3312 · Cited by 359 · see citing works
Bragin, E., Chatzimichali, E. A., Wright, C. F., Hurles, M. E., Firth, H. V., Bevan, A. P., & Swaminathan, G. J. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt937 · Cited by 233 · see citing works
Self-citationInsights into genetics, human biology and disease gleaned from family based genomic studies
Posey, J. E., O’Donnell‐Luria, A., Chong, J. X., Harel, T., Jhangiani, S. N., Coban‐Akdemir, Z., Buyske, S. G., Pehli̇van, D., Carvalho, C. M. B., Baxter, S. M., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0408-7 · Cited by 198 · see citing works
Flexible and scalable diagnostic filtering of genomic variants using G2P with Ensembl VEP
Thormann, A., Halachev, M., McLaren, W., Moore, D. J., Svinti, V., Campbell, A., Kerr, S. M., Tischkowitz, M., Hunt, S. E., Dunlop, M. G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10016-3 · Cited by 151 · see citing works
Self-citationAnsari, M., Poke, G., Ferry, Q. R. V., Williamson, K. A., Aldridge, R. C. L., Meynert, A. M., Bengani, H., Chan, C. Y., Kayserili, H., Avcı, Ş., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102573 · Cited by 164 · see citing works
Self-citationBCL11A Haploinsufficiency Causes an Intellectual Disability Syndrome and Dysregulates Transcription
Dias, C., Estruch, S. B., Graham, S. A., McRae, J. F., Sawiak, S. J., Hurst, J. A., Joss, S. K., Holder, S., Morton, J. E. V., Turner, C., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.05.030 · Cited by 162 · see citing works
Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays.
Chen, A., Liao, S., Cheng, M., Ma, K., Wu, L. L., Lai, Y., Qiu, X., Yang, J., Xu, J., Hao, S., et al. (2022) · Apollo (University of Cambridge) · Cited by 154 · see citing works
Weiss, K., Terhal, P. A., Cohen, L., Bruccoleri, M., Irving, M. D., Martinez, A. F., Rosenfeld, J. A., Machol, K., Yang, Y., Liu, P., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.08.001 · Cited by 140 · see citing works
Homozygous and hemizygous CNV detection from exome sequencing data in a Mendelian disease cohort
Gambin, T., Coban‐Akdemir, Z., Yuan, B., Gu, S., Chiang, T., Carvalho, C. M. B., Shaw, C. A., Jhangiani, S. N., Boone, P. M., Eldomery, M. K., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1237 · Cited by 125 · see citing works
Westbury, S. K., Turro, E., Greene, D. J., Lentaigne, C., Kelly, A. M., Bariana, T. K., Simeoni, I., Pillois, X., Attwood, A., Austin, S. K., et al. (2015) · Genome Medicine · doi:10.1186/s13073-015-0151-5 · Cited by 124 · see citing works
Gasc, C., Peyretaillade, É., & Peyret, P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw309 · Cited by 114 · see citing works
Molecular Genetics and Complex Inheritance of Congenital Heart Disease
Diab, N. S., Barish, S., Dong, W., Zhao, S., Allington, G., Yu, X., Kahle, K. T., Brueckner, M. K., & Jin, S. C. (2021) · Genes · doi:10.3390/genes12071020 · Cited by 112 · see citing works
Systematic discovery of protein interaction interfaces using AlphaFold and experimental validation
Lee, C. Y., Hubrich, D., Varga, J. K., Schäfer, C., Welzel, M., Schumbera, E., Djokic, M., Strom, J. M., Schönfeld, J., Geist, J. L., et al. (2024) · Molecular Systems Biology · doi:10.1038/s44320-023-00005-6 · Cited by 105 · see citing works
“A list of NDD genes was assembled using whole exome and whole genome sequencing studies of cohorts of NDD patients from Gene4Denovo (Zhao et al, 2020) and Deciphering Developmental Disorders (DDD) study (Firth et al, 2011), respectively.”
Systematic discovery of protein interaction interfaces using AlphaFold and experimental validation
Lee, C. Y., Hubrich, D., Varga, J. K., Schäfer, C., Welzel, M., Schumbera, E., Đokić, M., Strom, J. M., Schönfeld, J., Geist, J. L., et al. (2023) · doi:10.1101/2023.08.07.552219 · Cited by 105 · see citing works
Japan’s initiative on rare and undiagnosed diseases (IRUD): towards an end to the diagnostic odyssey
Adachi, T., Kawamura, K., Furusawa, Y., Nishizaki, Y., Imanishi, N., Umehara, S., Izumi, K., & Suematsu, M. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2017.106 · Cited by 103 · see citing works
McEntagart, M., Williamson, K. A., Rainger, J. K., Wheeler, A. P., Seawright, A., Baere, E. B. W. D., Verdin, H., Bergendahl, L. T., Quigley, A. J., Rainger, J., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.03.018 · Cited by 101 · see citing works
King, D. A., Fitzgerald, T. W., Miller, R., Canham, N. L. E., Clayton‐Smith, J., Johnson, D. S., Mansour, S., Stewart, F. A., Vasudevan, P. C., Hurles, M. E., et al. (2013) · Genome Research · doi:10.1101/gr.160465.113 · Cited by 93 · see citing works
Wright, C. F., Prigmore, E., Rajan, D., Handsaker, J., McRae, J. F., Kaplanis, J., Fitzgerald, T. W., FitzPatrick, D. R., Firth, H. V., & Hurles, M. E. (2019) · Nature Communications · doi:10.1038/s41467-019-11059-2 · Cited by 86 · see citing works
Self-citationGeoffroy, V., Guignard, T., Kress, A., Gaillard, J., Solli-Nowlan, T., Schalk, A., Gâtinois, V., Dollfus, H., Scheidecker, S., & Muller, J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab402 · Cited by 87 · see citing works
Catalytic deficiency of O-GlcNAc transferase leads to X-linked intellectual disability
Pravatà, V. M., Muha, V., Gundogdu, M., Ferenbach, A. T., Kakade, P. S., Vandadi, V., Wilmes, A. C., Borodkin, V. S., Joss, S. K., Stavridis, M. P., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1900065116 · Cited by 86 · see citing works
Swaminathan, G. J., Bragin, E., Chatzimichali, E., Corpas, M., Bevan, A. P., Wright, C. F., Carter, N. P., Hurles, M. E., & Firth, H. V. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds362 · Cited by 78 · see citing works
Self-citationSpatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball patterned arraysPreprint
Chen, A., Liao, S., Cheng, M., Ma, K., Wu, L., Lai, Y., Qiu, X., Yang, J., Li, W., Xu, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.17.427004 · Cited by 74 · see citing works
The Growing Importance of CNVs: New Insights for Detection and Clinical Interpretation
Valsesia, A., Macé, A., Jacquemont, S., Beckmann, J., & Kutalik, Z. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00092 · Cited by 72 · see citing works
Hamilton, M., Newbury-Ecob, R. A., Holder‐Espinasse, M., Yau, S., Lillis, S., Hurst, J. A., Clement, E. M., Reardon, W., Joss, S. K., Hobson, E., et al. (2016) · Clinical Dysmorphology · doi:10.1097/mcd.0000000000000143 · Cited by 75 · see citing works
Johnson, J. L., Stoica, L., Liu, Y., Zhu, P., Bhattacharya, A., Buffington, S. A., Huq, R., Eissa, N. T., Larsson, O. S., Porse, B. T., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.08.027 · Cited by 77 · see citing works
De Novo Mutations in EBF3 Cause a Neurodevelopmental Syndrome
Sleven, H., Welsh, S. J., Yu, J., Churchill, M. E. A., Wright, C. F., Henderson, A., Horváth, R., Rankin, J., Vogt, J., Magee, A. C., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.11.020 · Cited by 73 · see citing works
Self-citationVialle, R. A., Lopes, K. D. P., Bennett, D. A., Crary, J. F., & Raj, T. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01031-7 · Cited by 64 · see citing works
Further delineation of the KAT6B molecular and phenotypic spectrum
study, D., Gannon, T., Perveen, R., Schlecht, H., Ramsden, S., Anderson, B., Kerr, B. A., Day, R., Banka, S., Suri, M., et al. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.248 · Cited by 65 · see citing works
Franco, E. D., Watson, R. A., Weninger, W. J., Wong, C. C., Flanagan, S. E., Caswell, R. C., Green, A., Tudor, C. L., Lelliott, C. J., Geyer, S. H., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.03.018 · Cited by 64 · see citing works
Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variation
Radford, E. J., Tan, H.-K., Andersson, M. H. L., Stephenson, J. D., Gardner, E. J., Ironfield, H., Waters, A. J., Gitterman, D. P., Lindsay, S., Abascal, F., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43041-4 · Cited by 63 · see citing works
Self-citationGuo, H., Bettella, E., Marcogliese, P. C., Zhao, R., Andrews, J. C., Nowakowski, T. J., Gillentine, M. A., Hoekzema, K., Wang, T., Wu, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12435-8 · Cited by 61 · see citing works
Pravatà, V. M., Gundogdu, M., Bartual, S. G., Ferenbach, A. T., Stavridis, M. P., Õunap, K., Pajusalu, S., Žordania, R., Wojcik, M. H., & van Aalten, D. M. F. (2019) · FEBS Letters · doi:10.1002/1873-3468.13640 · Cited by 60 · see citing works
Mosaic structural variation in children with developmental disorders
King, D. A., Jones, W. D., Crow, Y. J., Dominiczak, A. F., Foster, N. A., Gaunt, T. R., Harris, J., Hellens, S. W., Homfray, T., Innes, J., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv033 · Cited by 59 · see citing works
Encephalopathies with KCNC1 variants: genotype‐phenotype‐functional correlations
Cameron, J. M., Maljevic, S., Nair, U., Aung, Y. H., Cogné, B., Bezieau, S., Blair, E. M., Isidor, B., Zweier, C., Reis, A., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50822 · Cited by 57 · see citing works
Using Drosophila to drive the diagnosis and understand the mechanisms of rare human diseases
Link, N., & Bellen, H. J. (2020) · Development · doi:10.1242/dev.191411 · Cited by 56 · see citing works
Ostrowski, P. J., Zachariou, A., Loveday, C., Beleza‐Meireles, A., Bértoli, M., Dean, J., Douglas, A. G. L., Ellis, I., Foster, A. C., Graham, J. M., et al. (2019) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31749 · Cited by 55 · see citing works
A framework to score the effects of structural variants in health and diseasePreprint
Kleinert, P., & Kircher, M. (2022) · Genome Research · doi:10.1101/gr.275995.121 · Cited by 55 · see citing works
Detection of structural mosaicism from targeted and whole-genome sequencing dataPreprint
King, D. A., Sifrim, A., Fitzgerald, T. W., Rahbari, R., Hobson, E., Homfray, T., Mansour, S., Mehta, S. G., Shehla, M., Tomkins, S. E., et al. (2017) · Genome Research · doi:10.1101/gr.212373.116 · Cited by 54 · see citing works
Cafferkey, M., Ahn, J. W., Flinter, F., & Ogilvie, C. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36554 · Cited by 92 · see citing works
The clinical presentation caused by truncating <i>CHD8</i> variants
Douzgou, S., Liang, H. W., Metcalfe, K., Somarathi, S., Tischkowitz, M., Mohamed, W., Kini, U., McKee, S., Yates, L., Bertoli, M., et al. (2019) · Clinical Genetics · doi:10.1111/cge.13554 · Cited by 52 · see citing works
AI-MARRVEL — A Knowledge-Driven AI System for Diagnosing Mendelian Disorders
Mao, D., Liu, C., Wang, L., AI-Ouran, R., Deisseroth, C., Pasupuleti, S., Kim, S. Y., Li, L., Rosenfeld, J. A., Meng, L., et al. (2024) · NEJM AI · doi:10.1056/aioa2300009 · Cited by 51 · see citing works
Weiss, K., Wigby, K. M., Fannemel, M., Henderson, L. B., Beck, N. M., Ghali, N., Study, D. D. D., Anderlid, B., Lundin, J., Hamosh, A., et al. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2017.86 · Cited by 46 · see citing works
Genome annotation for clinical genomic diagnostics: strengths and weaknesses
Steward, C. A., Parker, A. P. J., Minassian, B. A., Sisodiya, S. M., Frankish, A., & Harrow, J. (2017) · Genome Medicine · doi:10.1186/s13073-017-0441-1 · Cited by 48 · see citing works
Birnbaum, R., Mahjani, B., Loos, R. J. F., & Sharp, A. J. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.4080 · Cited by 45 · see citing works
Novel bioinformatic developments for exome sequencing
Lelieveld, S. H., Veltman, J. A., & Gilissen, C. (2016) · Human Genetics · doi:10.1007/s00439-016-1658-6 · Cited by 44 · see citing works
Hamilton, M. J., Caswell, R. C., Canham, N., Cole, T., Firth, H. V., Foulds, N., Heimdal, K., Hobson, E., Houge, G., Joss, S., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-104620 · Cited by 43 · see citing works
Self-citationStrategies to Uplift Novel Mendelian Gene Discovery for Improved Clinical Outcomes
Seaby, E. G., Rehm, H. L., & O’Donnell‐Luria, A. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.674295 · Cited by 39 · see citing works
Owen, C. I., Bowden, A. R., Parker, M. J., Patterson, J., Patterson, J., Price, S., Sarkar, A., Castle, B., Deshpande, C., Splitt, M. P., et al. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38610 · Cited by 39 · see citing works
Few shot learning for phenotype-driven diagnosis of patients with rare genetic diseases
Alsentzer, E., Li, M. M., Kobren, S. N., Noori, A., Undiagnosed Diseases Network, Kohane, I. S., & Zitnik, M. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01749-1 · Cited by 54 · see citing works
A Refined Approach to Evaluating Global Developmental Delay for the International Medical Community
Jiménez-Gómez, A., & Standridge, S. M. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.12.018 · Cited by 34 · see citing works
Hamilton, M., & Suri, M. (2018) · Advances in genetics · doi:10.1016/bs.adgen.2018.11.001 · Cited by 31 · see citing works
De novo variants in CNOT3 cause a variable neurodevelopmental disorder
Martin, R., Splitt, M. P., Geneviève, D., Aten, E., Collins, A. R., de Bie, C. I., Faivre, L. O., Foulds, N. C., Giltay, J. C., Ibitoye, R., et al. (2019) · European Journal of Human Genetics · doi:10.1038/s41431-019-0413-6 · Cited by 30 · see citing works
Sugiki, T., Egawa, D., Kumagai, K., Kojima, C., Fujiwara, T., Takeuchi, K., Shimada, I., Hanada, K., & Takahashi, H. K. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002465 · Cited by 30 · see citing works
Bayat, A., Knaus, A., Juul, A. W., Đukić, D., Gardella, E., Charzewska, A., Clement, E. M., Hjalgrim, H., Hoffman‐Zacharska, D., Horn, D., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0512-3 · Cited by 28 · see citing works
Gerrard, D. T., Berry, A. A., Jennings, R. E., Birket, M. J., Zarrineh, P., Garstang, M. G., Withey, S., Short, P., Jiménez-Gancedo, S., Firbas, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17305-2 · Cited by 26 · see citing works
Lahm, H., Schön, P., Doppler, S. A., Dreßen, M., Cleuziou, J., Deutsch, M.-A., Ewert, P., Lange, R., & Krane, M. (2015) · Current Genomics · doi:10.2174/1389202916666150303232520 · Cited by 27 · see citing works
Computational analysis of neurodevelopmental phenotypes: Harmonization empowers clinical discovery
Lewis‐Smith, D., Parthasarathy, S., Xian, J., Kaufman, M. C., Ganesan, S., Galer, P. D., Thomas, R. H., & Helbig, I. (2022) · Human Mutation · doi:10.1002/humu.24389 · Cited by 21 · see citing works
Atypical face shape and genomic structural variants in epilepsy
Chinthapalli, K., Bartolini, E., Nový, J., Suttie, M., Marini, C., Falchi, M., Fox, Z. V., Clayton, L. M. S., Sander, J. W. A. S., Guerrini, R., et al. (2012) · Brain · doi:10.1093/brain/aws232 · Cited by 26 · see citing works
Exome Sequencing in Fetuses with Structural Malformations
Mackie, F. L., Carss, K., Hillman, S., Hurles, M. E., & Kilby, M. D. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3030747 · Cited by 25 · see citing works
In vitro screening of embryos by whole-genome sequencing: now, in the future or never?
Winand, R., Hens, K., Dondorp, W., de Wert, G. M. W. R., Moreau, Y., Vermeesch, J. R., Liebaers, I., & Aerts, J. A. (2014) · Human Reproduction · doi:10.1093/humrep/deu005 · Cited by 25 · see citing works
Study, O. B. O. T. D., Middleton, A., Bragin, E., & Parker, M. J. (2014) · Journal of Community Genetics · doi:10.1007/s12687-014-0184-2 · Cited by 25 · see citing works
Schirwani, S., Albaba, S., Carere, D. A., Sacoto, M. J. G., Zamora, F. M., Si, Y. C., Rabin, R., Pappas, J., Renaud, D. L., Hauser, N., et al. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62465 · Cited by 25 · see citing works
Omelková, M., Fenger, C., Murray, M., Hammer, T. B., Pravatà, V. M., Bartual, S. G., Czajewski, I., Bayat, A., Ferenbach, A. T., Stavridis, M. P., et al. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049132 · Cited by 25 · see citing works
Samarakoon, P. S., Sorte, H. S., Stray‐Pedersen, A., Rødningen, O. K., Rognes, T., & Lyle, R. (2016) · BMC Genomics · doi:10.1186/s12864-016-2374-2 · Cited by 25 · see citing works
Dorn, C., Grunert, M., & Sperling, S. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/elt040 · Cited by 23 · see citing works
Zahir, F., Mwenifumbo, J. C., Chun, H.-J. E., Lim, E. L., van Karnebeek, C., Couse, M., Mungall, K. L., Lee, L., Makela, N., Armstrong, L., et al. (2017) · BMC Genomics · doi:10.1186/s12864-017-3671-0 · Cited by 24 · see citing works
Jones, G. E., Johnson, K. E., Eason, J., Hamilton, M., Osio, D., Kanani, F., Baptista, J., & Suri, M. (2022) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2022.104572 · Cited by 23 · see citing works
Middleton, A., Bragin, E., Morley, K. I., & Parker, M. J. (2013) · Social Science Research · doi:10.1016/j.ssresearch.2013.12.004 · Cited by 23 · see citing works
Meyer, R., Begemann, M., Demuth, S., Kraft, F., Dey, D., Schüler, H. M., Busse, S., Häusler, M., Zerres, K., Kurth, I., et al. (2020) · Clinical Genetics · doi:10.1111/cge.13819 · Cited by 23 · see citing works
Lewis, C., Hammond, J., Hill, M. K., Searle, B. A., Hunter, A., Patch, C., Chitty, L. S., & Sanderson, S. C. (2020) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2020.104043 · Cited by 23 · see citing works
Seaby, E. G., Smedley, D. P., Tavares, A. L. T., Brittain, H. K., van Jaarsveld, R. H., Baralle, D., Rehm, H. L., O’Donnell‐Luria, A., & Ennis, S. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.04.019 · Cited by 23 · see citing works
Senarathne, U. D., Indika, N.-L. R., Jezela‐Stanek, A., Ciara, E., Frye, R. E., Chen, C., & Stępień, K. M. (2023) · Genes · doi:10.3390/genes14040803 · Cited by 22 · see citing works
Zucca, S., Nicora, G., Paoli, F. D., Carta, M. G., Bellazzi, R., Magni, P., Rizzo, E., & Limongelli, I. (2024) · Human Genetics · doi:10.1007/s00439-023-02638-x · Cited by 22 · see citing works
Transcriptome-wide outlier approach identifies individuals with minor spliceopathies
Maurer, T. M., Mendez, R., Ungar, R. A., Bonner, D. E., Matalon, D. R., Lemire, G., Goddard, P. C., Padhi, E. M., Miller, A. M., Nguyen, J. V., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.08.018 · Cited by 19 · see citing works
Genome sequencing data analysis for rare disease gene discovery
Umlai, U. I., Bangarusamy, D. K., Estivill, X., & Jithesh, P. V. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab363 · Cited by 18 · see citing works
Empirical research on the ethics of genomic research
Middleton, A., Parker, M. J., Wright, C. F., Bragin, E., Hurles, M. E., & Study, O. B. O. T. D. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36067 · Cited by 19 · see citing works
Self-citationDiquigiovanni, C., Bergamini, C., Diaz, R., Liparulo, I., Bianco, F., Masin, L., Baldassarro, V. A., Rizzardi, N., Tranchina, A., Buscherini, F., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802722r · Cited by 19 · see citing works
Enabling Global Clinical Collaborations on Identifiable Patient Data: The Minerva Initiative
Nellåker, C., Alkuraya, F. S., Baynam, G. S., Bernier, R., Bernier, F. P., Boulanger, V. M., Brudno, M., Brunner, H. G., Clayton‐Smith, J., Cogné, B., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00611 · Cited by 19 · see citing works
Self-citation1q24 deletion syndrome. Two cases and new insights into genotype‐phenotype correlations
Lefroy, H., Fox, O., Javaid, M. K., Makaya, T., & Shears, D. J. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.40426 · Cited by 18 · see citing works
Pathogenic KDM5B variants in the context of developmental disorders
Harrington, J., Wheway, G., Willaime‐Morawek, S., Gibson, J., & Walters, Z. S. (2022) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2022.194848 · Cited by 18 · see citing works
Abbott, M., McKenzie, L. C., Morán, B. V. G., Heidenreich, S., Hernández, R. A., Hocking, L. J., Clark, C., Gomes, J., Lampe, A., Baty, D. U., et al. (2021) · Journal of Community Genetics · doi:10.1007/s12687-021-00541-4 · Cited by 17 · see citing works
Automated prediction of the clinical impact of structural copy number variations
Gažiová, M., Sládeček, T., Pös, O., Stevko, M., Krampl, W., Pös, Z., Hekel, R., Hlavacka, M., Kucharík, M., Radvánszky, J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-04505-z · Cited by 17 · see citing works
Darvish, H., Azcona, L. J., Tafakhori, A., Mesias, R., Ahmadifard, A., Sánchez, E., Habibi, A., Alehabib, E., Johari, A. H., Emamalizadeh, B., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-57929-4 · Cited by 17 · see citing works
PheNominal: an EHR-integrated web application for structured deep phenotyping at the point of care
Havrilla, J. M., Singaravelu, A., Driscoll, D. M., Minkovsky, L., Helbig, I., Medne, L., Wang, K., Krantz, I. D., & Desai, B. R. (2022) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-01927-1 · Cited by 15 · see citing works
Mary, L., Nourisson, E., Feger, C., Laugel, V., Chaigne, D., Keren, B., Afenjar, A., de Villemeur, T. B., Trost, D., Cieuta‐Walti, C., et al. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62181 · Cited by 16 · see citing works
Interpretation of Genomic Copy Number Variants Using DECIPHER
Corpas, M., Bragin, E., Clayton, S., Bevan, A. P., & Firth, H. V. (2012) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0814s72 · Cited by 15 · see citing works
Self-citationMolecular mechanisms of β-cell dysfunction and death in monogenic forms of diabetes
Caballero, L. S., Gorgogietas, V. A., Arroyo, M. N., & Igoillo‐Esteve, M. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.02.005 · Cited by 16 · see citing works
The GA4GH Phenopacket schema: A computable representation of clinical data for precision medicinePreprint
Jacobsen, J. O. B., Baudis, M., Baynam, G. S., Beckmann, J. S., Beltrán, S., Callahan, T. J., Chute, C. G., Courtot, M., Daniš, D., Elemento, O., et al. (2021) · medRxiv · doi:10.1101/2021.11.27.21266944 · Cited by 15 · see citing works
Copeland, H., Kivuva, E. C., Firth, H. V., & Wright, C. F. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01110-3 · Cited by 14 · see citing works
Self-citationGurasashvili, J., Silverio, S. A., Hill, M., Peter, M., Stafford‐Smith, B., & Lewis, C. (2024) · Journal of Genetic Counseling · doi:10.1002/jgc4.1818 · Cited by 13 · see citing works
Loong, L., Tardivo, A., Knaus, A., Hashim, M., Pagnamenta, A. T., Alt, K., Böhrer‐Rabel, H., Caro‐Llopis, A., Cole, T. R. P., Distelmaier, F., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.09.007 · Cited by 13 · see citing works
Genomics and Patient Empowerment
McAllister, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420195-8.00003-3 · Cited by 13 · see citing works
Clinical and Neurobiological Aspects of TAO Kinase Family in Neurodevelopmental Disorders
Hu, C., Feng, P., Yang, Q., & Xiao, L. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.655037 · Cited by 13 · see citing works
- Authors
- FIRTH, H. V., WRIGHT, C. F., & Study, F. T. D.
- Affiliations
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Wellcome Sanger Institute (GB)
- Venue
- Developmental Medicine & Child Neurology
- Publisher
- Wiley
- Published
- 2011-06-17
- Volume
- 53
- Issue
- 8
- Pages
- 702-703
- ISSN
- 0012-1622 (ISSN-L)
- OpenAlex
- W2055032549
- Cited by
- 180
- References
- 10
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 11 · 2023: 15 · 2022: 22 · 2021: 23 · 2020: 10 · 2019: 21 · 2018: 15 · 2017: 10 · 2016: 11 · 2015: 8 · 2014: 9 · 2013: 8 · 2012: 4
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Developmental Medicine & Child Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- National Institute for Health and Care Research
- University of Cambridge
- Cambridge University Hospitals
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- genetic diagnosis, intellectual disability, de novo mutations, recessive inheritance, consanguinity, structural variants, genomic microarrays, exome sequencing, whole genome sequencing, phenotyping, rare variants, pediatric neurology, medical genetics
- MeSH terms
- Child, Developmental Disabilities, Disability Evaluation, Genetic Testing, United Kingdom, Humans, Computational Biology, Genetic Predisposition to Disease, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
